NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Devices · USD

GlucoTrack, Inc. (GCTK) Stock Analysis

GlucoTrack, Inc. (GCTK) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

GCTK

$2.98

−$0.34 (−10.24%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare GCTK with… →

GCTK Key Statistics

As of Sep 4, 2026
Trading
Open
$3.26
Previous Close
$3.32
Day's Range
2.95–3.31
52-Week Range
2.95–212.10
Volume
72.20K
Valuation
Market Cap
$2.38M
P/E Ratio
0.19
EPS (ttm)Profit attributable to each share over the last twelve months.
15.38
Financials (FY)
Revenue (FY)
$0.00
Net Income (FY)
−$19.39M
Profit marginThe share of revenue left as profit after all costs and taxes.
0.00%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
798.14K
1-Year Return
−38.81%
Dividend and dates
Avg Volume
754.93K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

GCTK Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−23.00%
2025−99.14%
2024−71.53%
2023−81.42%
2022−66.19%
2021−9.64%
2020−40.83%
2019+20.00%
2018−75.00%
2017−20.00%
2016 (partial year)−12.89%

As of September 4, 2026.

GCTK Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$0.00−$19.39M—
2024$0.00−$22.60M—
2023$0.00−$7.10M—
2022$0.00−$4.44M—
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$0.00—−$16.09M−$19.39M—
2024$0.00—−$14.55M−$22.60M—
2023$0.00—−$7.10M−$7.10M—
2022$0.00—−$4.43M−$4.44M—

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

GCTK Valuation vs Medical Devices Median

Median of 151 stocks
MetricGCTKMedical Devices medianvs median
P/E0.1926.800.0x the median
Profit margin0.00%−1.69%1.7 pts above

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values GlucoTrack, Inc. (GCTK) at $2.38M. The company sits in the Healthcare sector, in the Medical Devices industry. The company reports 15 employees.

The most recent close on file for GCTK is $2.98, dated September 4, 2026. That is −$0.34 (−10.24%) against the previous close. The 52-week range on file runs from $2.95 to $212.10. The latest close sits 1.02% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $0.00. The same year closed with a net loss of $19.39M. The reported profit margin is 0%. That is 1.7 percentage points above the Medical Devices median of −1.69%. Earnings per share on a trailing basis come to 15.38.

Across the 4 fiscal years on file, revenue moves from $0.00 in 2022 to $0.00 in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

On trailing earnings, the shares are priced at 0.19 times earnings. That is 0 times the Medical Devices median of 26.8. The medians here are taken across 151 Medical Devices companies that report the metric.

Over the trailing twelve months the price has returned −38.81%. Measured over 10 years, that is −67.66% a year compounded. Daily returns over the trailing 10 years annualize to a volatility of 497.99%.

Growth & Income

No dividend is on file for GCTK.

2026 is still running; the price is −23.00% year to date. The strongest complete calendar year on file is 2019 at +20.00%; the weakest is 2025 at −99.14%. Of the 9 complete calendar years on file, 1 finished higher.

Peer Comparison

GlucoTrack, Inc. (GCTK) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
GlucoTrack, Inc. GCTK $2.38M 0.2
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. GlucoTrack, Inc. trades at a P/E of 0.2.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About GlucoTrack, Inc.

GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

Visit website →